CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

130 hedge funds and large institutions have $251M invested in Cymabay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

62% less call options, than puts

Call options by funds: $1.32M | Put options by funds: $3.45M

Holders
130
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.32M
Puts
$3.45M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$46.8M
2
$27.1M
3
$18.2M
4
$16.8M
5
$13.5M
6
$9.85M
7
$9.32M
8
$8.11M
9
$7.45M
10
$7.18M
11
$6.58M
12
$6M
13
$5.98M
14
$5.86M
15
$5.25M
16
$4.66M
17
$4.34M
18
$4.04M
19
$3.13M
20
$2.55M
21
$2.47M
22
$2.45M
23
$2.36M
24
$1.64M
25
$1.53M